I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 8 studies | 34% ± 16% | |
| GABAergic neuron | 4 studies | 32% ± 10% | |
| interneuron | 3 studies | 22% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 8 studies | 34% ± 16% | |
| GABAergic neuron | 4 studies | 32% ± 10% | |
| interneuron | 3 studies | 22% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 30% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 96% | 900.88 | 248 / 258 | 86% | 16.51 | 197 / 230 |
| ovary | 100% | 11607.54 | 180 / 180 | 73% | 4.93 | 312 / 430 |
| brain | 93% | 3203.74 | 2469 / 2642 | 78% | 9.60 | 551 / 705 |
| kidney | 91% | 942.47 | 81 / 89 | 77% | 7.30 | 696 / 901 |
| prostate | 84% | 810.43 | 205 / 245 | 83% | 4.56 | 415 / 502 |
| stomach | 100% | 1614.70 | 358 / 359 | 45% | 3.79 | 129 / 286 |
| uterus | 81% | 1039.22 | 138 / 170 | 56% | 4.04 | 259 / 459 |
| thymus | 36% | 199.92 | 233 / 653 | 76% | 5.42 | 462 / 605 |
| esophagus | 49% | 449.23 | 713 / 1445 | 60% | 4.22 | 109 / 183 |
| breast | 42% | 255.29 | 193 / 459 | 64% | 3.55 | 713 / 1118 |
| muscle | 100% | 3452.90 | 803 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 90% | 8.36 | 72 / 80 |
| bladder | 62% | 823.24 | 13 / 21 | 27% | 1.28 | 138 / 504 |
| blood vessel | 86% | 1509.08 | 1151 / 1335 | 0% | 0 | 0 / 0 |
| pancreas | 13% | 64.80 | 41 / 328 | 70% | 4.01 | 124 / 178 |
| tonsil | 0% | 0 | 0 / 0 | 78% | 7.62 | 35 / 45 |
| skin | 6% | 30.09 | 100 / 1809 | 71% | 13.64 | 336 / 472 |
| intestine | 33% | 247.80 | 323 / 966 | 30% | 2.05 | 156 / 527 |
| heart | 62% | 393.02 | 537 / 861 | 0% | 0 | 0 / 0 |
| lung | 7% | 37.89 | 40 / 578 | 51% | 3.95 | 592 / 1155 |
| liver | 7% | 33.88 | 15 / 226 | 43% | 2.60 | 174 / 406 |
| adipose | 20% | 125.97 | 238 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 0.23 | 3 / 29 |
| spleen | 3% | 13.13 | 7 / 241 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0042147 | Biological process | retrograde transport, endosome to Golgi |
| GO_0034314 | Biological process | Arp2/3 complex-mediated actin nucleation |
| GO_0007283 | Biological process | spermatogenesis |
| GO_0006887 | Biological process | exocytosis |
| GO_0030154 | Biological process | cell differentiation |
| GO_0032456 | Biological process | endocytic recycling |
| GO_0071203 | Cellular component | WASH complex |
| GO_0005829 | Cellular component | cytosol |
| GO_0055037 | Cellular component | recycling endosome |
| GO_0005769 | Cellular component | early endosome |
| GO_0043015 | Molecular function | gamma-tubulin binding |
| GO_0043014 | Molecular function | alpha-tubulin binding |
| GO_0003779 | Molecular function | actin binding |
| Gene name | WIPF3 |
| Protein name | WAS/WASL-interacting protein family member 3 (Corticosteroids and regional expression protein 16 homolog) WAS/WASL interacting protein family member 3 |
| Synonyms | CR16 |
| Description | FUNCTION: May be a regulator of cytoskeletal organization. May have a role in spermatogenesis (By similarity). . |
| Accessions | A6NGB9 ENST00000242140.10 A0A0A0MSG0 ENST00000409123.5 |
